Novartis - Comment

Document ID: FDA-2010-D-0462-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 11 2010, at 12:00 AM Eastern Standard Time
Date Posted: November 18 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: September 14 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: November 15 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80b87243
View Document:  View as format xml

View Comment

Please see attached Novartis Comments on Draft Guidance: "Chronic Hepatitis C Virus Infection; Developing Direct-Acting Antiviral Agents forTreatment"

Attachments:

Novartis - Comment

Title:
Novartis - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 12
Merck & Co, Inc. - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0004

Nov 15,2010 11:59 PM ET
Novartis - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0006

Nov 15,2010 11:59 PM ET
GlaxoSmithKline - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0007

Nov 15,2010 11:59 PM ET
Merck & Company - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0008

Nov 15,2010 11:59 PM ET
Gilead Sciences Inc. - Comment
Public Submission    Posted: 11/18/2010     ID: FDA-2010-D-0462-0010

Nov 15,2010 11:59 PM ET